Martindale The Extra Pharmacopoeia, 29th ed.,
313-323 (1989).
4. Goodman and Gilman's The Pharmacological Basis
of Therapeutics, 7th ed., 1170-1171 (1985).
MAM 7/2003
Sigma brand products
IB, IF
100 ml €331
Anti-PARP-1 (197-214) Rabbit pAb 512738 Undiluted serum . Immunogen used was a synthetic peptide corresponding to amino acids
197-214 of human PARP . Recognizes the ~116 kDa full-length
cathepsin L compared to cathepsin B (Ki = 214 nM).
1 mg
Cathepsin L Inhibitor VI 219495 [N-(4-Biphenylacetyl)-S-methylcysteine-(D)-Arg-
Phe-ß-phenethylamide; Compound 7]
An end protected tripeptide that
* When used in RP mode.
www.merck-chemicals.com/analytical-hplc
Analytical HPLC
313
Column care and use
Column regeneration
Exposure of a column to samples or solvents containing
70 H5147 3303 HSPA1A M NP_005336.3 y n/d y
314 GRP78/BiP G8918 3309 HSPA5 P NP_005338.1 y y n/d
313 GRP 75 G4170 3313 HSPA9 P NP_004125.3 y y y
342 Heat Shock Protein 25 H0148 3315 HSPB1 M NP_001531.1
70 H5147 3303 HSPA1A M NP_005336.3 y n/d y
314 GRP78/BiP G8918 3309 HSPA5 P NP_005338.1 y y n/d
313 GRP 75 G4170 3313 HSPA9 P NP_004125.3 y y y
342 Heat Shock Protein 25 H0148 3315 HSPB1 M NP_001531.1
70 H5147 3303 HSPA1A M NP_005336.3 y n/d y
314 GRP78/BiP G8918 3309 HSPA5 P NP_005338.1 y y n/d
313 GRP 75 G4170 3313 HSPA9 P NP_004125.3 y y y
342 Heat Shock Protein 25 H0148 3315 HSPB1 M NP_001531.1
Lauric acid
4. n-Capric acid
Detection In-situ evaluation with TLC/HPTLC scanner (Camag) UV 313 nm
Application of reaction mixture a. Chromatogram of reaction mixture without fatty acids
b.
d n/d y
311 GRP1 G7670 116693, 9265 PSCD3,Pscd3 NP_446364.2,NP_004218.1 M y n/d y
312 Anti Cy3+Cy5
313 GRP 75 G4170 3313, 15526 HSPA9,Hspa9 NP_004125.3,NP_034611.2 P y y y
314 GRP78/BiP G8918 14828, 3309
y
311 GRP1 G6541 116693, 9265 PSCD3,Pscd3 NP_446364.2,NP_004218.1 M y n/d y
312 Anti Cy3+Cy5 C0992
313 GRP 75 G4170 3313, 15526 HSPA9,Hspa9 NP_004125.3,NP_034611.2 P y y y
314 GRP78/BiP G8918 14828, 3309